Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

How Does Cannabis Interact With the Nervous System in CRPS Patients? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

CRPS  is a condition deeply rooted in nervous system dysfunction. From abnormal pain responses to heightened sensitivity, its symptoms suggest a malfunctioning system that requires adjustment. That’s where CBD for CRPS is gaining attention, for its ability to interact with the body’s internal regulatory system: the endocannabinoid system. 

Cannabis compounds, known as cannabinoids, help regulate nerve activity, inflammation, and pain perception. For patients with complex regional pain, CBD may offer a calming influence on overactive nerve signals, potentially reducing burning, tingling, and sudden pain surges. 

Book Consultation for Medical Cannabis

The Nervous System and Cannabis 

Here’s how cannabinoids like CBD for CRPS interact with the body: 

  • Modulating pain signalling 
    Cannabinoids influence CB1 and CB2 receptors found in the nervous system and immune cells. 
    By doing so, CBD for CRPS may reduce pain intensity and sensitivity in affected limbs. 
  • Easing inflammation and stress 
    Nerve pain often worsens with stress and inflammation. 
    CBD’s anti-inflammatory properties help soothe the nervous system, creating a more balanced internal state. 
  • Guiding safe and legal use 
    In the UK, access to medical cannabis, including legal use of CBD, is restricted to specialist prescriptions. 
    Understanding how and when to use it safely is crucial for patients navigating CRPS. 

While it won’t undo nerve damage, CBD for CRPS offers a gentler, more sustainable approach to managing symptoms and restoring quality of life. 

For in-person consultations and secure, expert-led cannabis care, contact providers such as LeafEase.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Complex Regional Pain Syndrome (CRPS). 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories